Integrated Care News by CFHA

MAY 8, 2025

Vaccine hesitancy is the delay in accepting or refusing vaccination despite the availability of vaccination services. It falls on a spectrum of vaccine attitudes and intentions, from those who recognize the importance of vaccines and accept all vaccines on one end of the spectrum to those who refuse all vaccines.

Vaccination 130

Vaccination Healthcare Professional Integrated Care Healthcare 130

Minnesota Academy of Family Physicians

JUNE 20, 2025

AAFP Denounces Changes to ACIP and Vaccine Recommendations The Minnesota Academy of Family Physicians (MAFP) stands with the American Academy of Family Physicians (AAFP) in denouncing the recent decisions made by Health and Human Services (HHS) Secretary, Robert F. Kennedy, Jr. Call to Action The MAFP urges members to speak out.

Family Physician 71

Family Physician Vaccination Family Families 71

Annals of Family Medicine

NOVEMBER 20, 2024

Context: The human papillomavirus (HPV) vaccine is recommended starting at age 9 to reduce risk of HPV linked squamous cell cancers, yet recent data shows that only 58.6% have been vaccinated by age 17. Secondary acceptance is agreeing to a vaccine subsequent to declining in a previous encounter. Child (e.g.,

Vaccination 130

Vaccination DO Family Medicine Primary Care 130

FDA Law Blog

JUNE 7, 2021

However, the FDA guidance goes on to say in some cases, additional context is needed by specifically inserting a sentence in the indications statement that: no clinical benefit has been established. be “reasonably likely to predict” ultimate clinical benefit). be “reasonably likely to predict” ultimate clinical benefit).

Clinic 98

Clinic IT Private Practice Utilities 98

FDA Law Blog

SEPTEMBER 30, 2024

CMS did not finalize the price verification survey, which would have required manufacturers of 10 costly drugs selected annually to provide clinical information as well as information on production, distribution, research, and marketing costs, revenue and profit, and ex-U.S. pricing, among other things.

Manufacturing 59

Manufacturing Utilities Provider IT 59

FDA Law Blog

JUNE 2, 2023

For 10 high-cost single source covered outpatient drugs selected annually by CMS, manufacturers would be required to respond to a so-called “price verification survey” by providing not only clinical and utilization information about the drug, but also costs of production, distribution, research, and marketing; revenue and profit; and ex-U.S.

Manufacturing 59

Manufacturing Vaccination Government Diagnosis 59

Doctors for America

APRIL 29, 2025

However, this assessment comes with alarm – essential services our patients rely on and that we as clinicians need to provide high-quality, evidence-based care have been obliterated by seemingly haphazard decision-making. The agency has also delayed vaccine advisory panels.

Medical Student 52

Medical Student Patients Individual Medical 52